title: Implementation and Evaluation  of a High-Dose Cytarabine Neurologic Assessment Tool.
abstract: Patients receiving high-dose cytarabine as part of their chemotherapy regimen have a chance of experiencing neurotoxicities. Prompt identification of signs and symptoms can greatly reduce the chance of patients sustaining permanent neurologic damage. This article describes the development and successful implementation of an evidence-based, standardized neurologic assessment and documentation tool that was evaluated using a clinical utility questionnaire and an adherence audit.
authors.affiliation: University of Maryland Medical Center in Baltimore.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Szoch
authors.affiliation: University of Maryland Medical Center in Baltimore.
authors.forename: Karen
authors.initials: K
authors.lastname: Snow Kaiser
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002983:Clinical Competence; D003561:Cytarabine / Q000008:administration & dosage* / Q000009:adverse effects; D004282:Documentation; D006801:Humans; D009460:Neurologic Examination; D009730:Nursing Assessment; D057184:Practice Patterns, Nurses'
chemical_list: D000970:Antineoplastic Agents; D003561:Cytarabine
keywords: clinical utility; documentation; high-dose cytarabine; neurologic assessment